Bayer is investing approximately US$2.2 billion to establish a new pharmaceutical manufacturing site in New Albany, Ohio, further strengthening its long-term manufacturing footprint in the United States.
📍 Location: New Albany, Ohio
💰 Investment: US$2.2 billion
👷 Employment: ~600 new jobs
🏭 Focus: Pharmaceutical manufacturing
📅 First module operational: Expected in 2031
📅 Second module: Planned for 2034
The new campus will initially support Bayer’s pharmaceutical portfolio across oncology, cardiovascular and renal care.
A major focus of the facility will be advanced automation, including automated mixing and sieving, material handling, coating suspension and tablet-pressing processes.
The company plans to develop the site through a step-by-step, flexible and modular approach. The first module will focus on drug-substance manufacturing, followed by a second module dedicated to drug-product manufacturing.
The investment adds to Bayer’s more than $7 billion invested in the US over the past five years, highlighting the company’s continued commitment to expanding its pharmaceutical manufacturing capabilities.
🇺🇸 The project is expected to strengthen the US pharmaceutical supply chain while creating significant opportunities across advanced manufacturing, engineering, technology and life sciences.
#Bayer #Pharmaceuticals #Pharma #Manufacturing #Ohio #USA #Investment #LifeSciences #Healthcare #Automation #AdvancedManufacturing #Jobs #PharmaManufacturing #IndustrialInvestment #USManufacturing
